HOME >> BIOLOGY >> NEWS
'PET/CT in Cancer Patient Management' examined in Journal of Nuclear Medicine Supplement

RESTON, Va. -- "PET/CT in Cancer Patient Management" is the subject of a special supplement to the January issue of the Journal of Nuclear Medicine. SNM, the largest molecular imaging and nuclear medicine association, is publishing a unique collection of articles that explores the role of 18F-FDG PET/CT imaging in patient screening, cancer diagnosis, initial treatment planning, treatment monitoring and detection of early recurrence.

"Oncologists, internists, general practitioners, radiologists and nuclear medicine physicians are frequently overwhelmed by the need to select--from among the different imaging modalities--the one that best serves the needs of their patients," notes the supplement's guest editor Johannes Czernin, the director of the Nuclear Medicine Clinic and professor and vice chair of molecular and medical pharmacology at the University of California, Los Angeles. "Despite the impressive growth of PET/CT, there is no consensus on the optimum clinical use of PET/CT and its implementation into patient management," he added, thereby prompting the publication of this exceptional resource.

"Selecting the 'best' PET/CT protocol for a given clinical problem adds another layer of complexity for referring physicians and practicing imaging specialists who need to avoid redundancies in diagnostic tests that frequently involve radiation," said Heinrich Schelbert, who is editor in chief of JNM, the most prominent peer-reviewed journal in nuclear medicine, molecular imaging and allied disciplines.

Doctors use positron emission tomography (PET) and computed tomography (CT) scans as standard imaging tools to pinpoint disease states in the body. When PET is used to image cancer, a radiopharmaceutical (such as fluorodeoxyglucose or FDG, which includes both a sugar and a radionuclide) is injected into a patient. Cancer cells metabolize sugar at higher rates than normal cells, and the radiopharmaceutical is drawn in higher concentrations
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
2-Jan-2007


Page: 1 2 3 4

Related biology news :

1. Journalists can register now for ECCO 14 -- the European Cancer Conference
2. Cancer cures could work for canines and humans
3. The Cancer Genome Atlas awards funds for technology development
4. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
5. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
6. Cancer stem cells can go it alone
7. Cancer drug enhances long-term memory
8. Cancer cells reprogram energy needs to grow and spread, study suggests
9. Cancer scientists create human leukemia process to map how disease begins, progresses
10. Cancer tip -- Nanoparticles can damage DNA, increase cancer risk
11. Other highlights from the April 18 Journal of the National Cancer Institute

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/9/2019)... ... ... With a demand in healthcare to lower unneeded emergency room visits and ... (UCC) in the coming years, according to a new report on the industry by ... , is a detailed look at the current state of these healthcare outlets, including ...
(Date:8/6/2019)... ... 2019 , ... VetStem Biopharma has long been ... experience. In November it spun out a human regenerative medicine subsidiary, ... of the first cGMP cell manufacturing facilities in California , VetStem signed ...
(Date:8/6/2019)... ... August 05, 2019 , ... ... announce its attendance at the Microscopy & Microanalysis 2019 Meeting ( M&M 2019 ... Oregon Convention Center. , The Microscopy & Microanalysis Meeting, organized by the Microscopy ...
Breaking Biology News(10 mins):
(Date:8/6/2019)... ... 2019 , ... Shoreline Biome, a microbiome research ... has announced partnerships with six international distributors. , The distributors will sell ... Australia, Benelux, Indonesia, Korea, Malaysia, Myanmar, New Zealand, Singapore, the United Kingdom, and ...
(Date:7/26/2019)... ... July 25, 2019 , ... LeadingBiotech , ... dialogue, today announces its Boston BD conference to be held on ... Biotech Week Boston , the event provides an opportunity for attendees to leverage ...
(Date:7/17/2019)... ... July 16, 2019 , ... ... and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for ... will have dedicated manufacturing space at the new, state-of-the-art commercial manufacturing center ...
(Date:7/2/2019)... ... , ... Leading Regenerative Veterinary Medicine company, VetStem Biopharma , was recently ... film focuses on regenerative veterinary medicine as a means of improving the quality of ... in the Brentwood and Pacific Palisades International Film Festival in Los Angeles, California where ...
Breaking Biology Technology:
Cached News: